Product Information
BORTEZOMIB 3.5 MG VIAL is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $43.3460 per EA under NDC 50742048401. Its NADAC has been published 48 times since May 22, 2024.
FDA first approved this application on May 2, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
3.5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742048401
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA210824FDA Approved
5/2/2022
TE Code
AP
On Market Since
5/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BORTEZOMIB 3.5 MG VIAL has been published 48 times since May 22, 2024, and over the history we have for it it has risen 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.3460 per EA |
|---|---|
| All-time high | $43.3460 (Apr 16, 2025) |
| All-time low | $29.6580 (May 22, 2024) |
| Median price | $34.7100 |
| Average price | $36.5803 |
| Largest weekly change | +24.9% (Dec 18, 2024) |
| Weeks tracked | 48 |
| Tracking since | May 22, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+46.2%
Last surveyed Apr 16, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BORTEZOMIB 3.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BORTEZOMIB 3.5 MG VIAL, manufactured by Ingenus Pharmaceuticals LLC, is $43.3460 per EA (NDC 50742048401), effective Apr 16, 2025.
How has the price of BORTEZOMIB 3.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for BORTEZOMIB 3.5 MG VIAL has risen 46.2%. It has been tracked across 48 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BORTEZOMIB 3.5 MG VIAL?
Since May 22, 2024, the NADAC for BORTEZOMIB 3.5 MG VIAL has ranged from a low of $29.6580 (May 22, 2024) to a high of $43.3460 (Apr 16, 2025), with a median of $34.7100 per EA.
Are there cheaper alternatives to BORTEZOMIB 3.5 MG VIAL?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BORTEZOMIB 3.5 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures BORTEZOMIB 3.5 MG VIAL?
BORTEZOMIB 3.5 MG VIAL (NDC 50742048401) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.